Beijing Hotgen Biotech Co Ltd
SSE:688068

Watchlist Manager
Beijing Hotgen Biotech Co Ltd Logo
Beijing Hotgen Biotech Co Ltd
SSE:688068
Watchlist
Price: 172.5 CNY -1.6%
Market Cap: 16B CNY

Wall Street
Price Targets

Price Targets Summary
Beijing Hotgen Biotech Co Ltd

There are no price targets for Beijing Hotgen Biotech Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Beijing Hotgen Biotech Co Ltd Competitors:
Price Targets
603259
WuXi AppTec Co Ltd
31% Upside
ILMN
Illumina Inc
14% Downside
2269
WuXi Biologics (Cayman) Inc
15% Upside
MTD
Mettler-Toledo International Inc
3% Upside
300463
Maccura Biotechnology Co Ltd
32% Upside
MCAP
MedCap AB (publ)
19% Upside
CSBR
Champions Oncology Inc
85% Upside
ABSI
Absci Corp
116% Upside

Revenue
Forecast

Revenue Estimate
Beijing Hotgen Biotech Co Ltd

For the last 7 years the compound annual growth rate for Beijing Hotgen Biotech Co Ltd's revenue is 20%. The projected CAGR for the next 3 years is 10%.

20%
Past Growth
10%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Beijing Hotgen Biotech Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Beijing Hotgen Biotech Co Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Beijing Hotgen Biotech Co Ltd's stock price target?
Not Available

Beijing Hotgen Biotech Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Beijing Hotgen Biotech Co Ltd's Revenue forecast?
Projected CAGR
10%

For the last 7 years the compound annual growth rate for Beijing Hotgen Biotech Co Ltd's revenue is 20%. The projected CAGR for the next 3 years is 10%.

Back to Top